Literature DB >> 30524603

Endovascular management of subclavian artery stenosis using balloon expandable covered stents.

Jon C George1, Brian O'Murchu1, Riyaz Bashir1.   

Abstract

Covered stents have primarily been used in coronary arteries for exclusion of perforations, aneurysms, and fistulas. The use of covered stents to treat occlusive disease of first-order aortic branches has been proposed as a method to reduce intimal hyperplasia and improve patency rates, since they exclude plaque and prevent luminal encroachment through open struts, but their selective use in subclavian artery stenosis has not been previously reported. We present three cases of subclavian artery stenosis that were successfully treated via a percutaneous approach with covered stents.

Entities:  

Keywords:  Covered stents; Endovascular intervention; Peripheral arterial disease; Subclavian artery stenosis

Year:  2011        PMID: 30524603      PMCID: PMC6265022          DOI: 10.1016/j.jccase.2011.02.004

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  4 in total

1.  Effect of polytetrafluoroethylene covering of Palmaz stents on the development of intimal hyperplasia in human iliac arteries.

Authors:  M L Marin; F J Veith; J Cynamon; R E Parsons; R T Lyon; W D Suggs; C W Bakal; S Waahl; L A Sanchez; J G Yuan; T Ohki
Journal:  J Vasc Interv Radiol       Date:  1996 Sep-Oct       Impact factor: 3.464

2.  Flemish experience using the Advanta V12 stent-graft for the treatment of iliac artery occlusive disease.

Authors:  M Bosiers; V Iyer; K Deloose; J Verbist; P Peeters
Journal:  J Cardiovasc Surg (Torino)       Date:  2007-02       Impact factor: 1.888

3.  Pathology of acute and chronic coronary stenting in humans.

Authors:  A Farb; G Sangiorgi; A J Carter; V M Walley; W D Edwards; R S Schwartz; R Virmani
Journal:  Circulation       Date:  1999 Jan 5-12       Impact factor: 29.690

4.  Balloon-expandable covered stent therapy of complex endovascular pathology.

Authors:  Heath Giles; Christopher Lesar; Luke Erdoes; Richard Sprouse; Stuart Myers
Journal:  Ann Vasc Surg       Date:  2008-10-15       Impact factor: 1.466

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.